Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$589M |
| 2 |
Meta Platforms (Facebook)
META
|
+$461M |
| 3 |
Digital Realty Trust
DLR
|
+$324M |
| 4 |
Tesla
TSLA
|
+$288M |
| 5 |
Dollar General
DG
|
+$202M |
Top Sells
| 1 |
HEICO Class A
HEI.A
|
+$561M |
| 2 |
UnitedHealth
UNH
|
+$256M |
| 3 |
Accenture
ACN
|
+$234M |
| 4 |
DRE
Duke Realty Corp.
DRE
|
+$229M |
| 5 |
Comcast
CMCSA
|
+$214M |
Sector Composition
| 1 | Technology | 18.14% |
| 2 | Healthcare | 13.63% |
| 3 | Financials | 13.11% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
BridgeBio Pharma
BBIO
$9.78B
| $3.17M | ﹤0.01% |
318,882
+275,673
| +638% | +$2.74M |
|
|
DADA
2352
DELISTED
Dada Nexus
DADA
| $3.16M | ﹤0.01% |
668,026
-31,439
| -4% | -$149K |
|
2353
Nelnet
NNI
$4.53B
| $3.16M | ﹤0.01% |
39,868
-5
| -0% | -$396 |
|
|
JRO
2354
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $3.15M | ﹤0.01% |
390,181
+93,372
| +31% | +$753K |
|
|
SIX
2355
DELISTED
Six Flags Entertainment Corp.
SIX
| $3.14M | ﹤0.01% |
177,160
+29,208
| +20% | +$517K |
|
2356
CEVA Inc
CEVA
$593M
| $3.13M | ﹤0.01% |
119,485
+8,032
| +7% | +$211K |
|
|
CTIC
2357
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $3.13M | ﹤0.01% |
536,883
-843,023
| -61% | -$4.91M |
|
2358
AMC Entertainment Holdings
AMC
$1.45B
| $3.12M | ﹤0.01% |
44,795
+1,336
| +3% | +$93.1K |
|
|
ETB
2359
Eaton Vance Tax-Managed Buy-Write Income Fund
ETB
$436M
| $3.12M | ﹤0.01% |
236,332
-28,031
| -11% | -$370K |
|
|
WIA
2360
Western Asset Inflation-Linked Income Fund
WIA
$197M
| $3.11M | ﹤0.01% |
347,289
+5,777
| +2% | +$51.7K |
|
2361
Allegiant Air
ALGT
$1.14B
| $3.1M | ﹤0.01% |
42,505
+5,851
| +16% | +$427K |
|
2362
Jackson Financial
JXN
$6.74B
| $3.1M | ﹤0.01% |
111,737
-1,420
| -1% | -$39.4K |
|
|
AFT
2363
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
| $3.09M | ﹤0.01% |
246,790
+25,272
| +11% | +$316K |
|
2364
Chegg
CHGG
$153M
| $3.08M | ﹤0.01% |
146,336
+4,835
| +3% | +$102K |
|
|
GBT
2365
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.06M | ﹤0.01% |
44,967
+3,488
| +8% | +$238K |
|
2366
Inogen
INGN
$225M
| $3.06M | ﹤0.01% |
126,053
+5,973
| +5% | +$145K |
|
|
PTRA
2367
DELISTED
Proterra Inc. Common Stock
PTRA
| $3.06M | ﹤0.01% |
613,788
+14,275
| +2% | +$71.1K |
|
2368
Progyny
PGNY
$1.86B
| $3.05M | ﹤0.01% |
82,425
+2,994
| +4% | +$111K |
|
|
MSD
2369
Morgan Stanley Emerging Markets Debt Fund
MSD
$154M
| $3.05M | ﹤0.01% |
495,280
+39,891
| +9% | +$246K |
|
2370
Teva Pharmaceuticals
TEVA
$21.1B
| $3.05M | ﹤0.01% |
378,142
+14,231
| +4% | +$115K |
|
2371
Coherus Oncology, Inc. Common Stock
CHRS
$157M
| $3.03M | ﹤0.01% |
315,633
-17,160
| -5% | -$165K |
|
2372
Empire State Realty Trust
ESRT
$1.27B
| $3.03M | ﹤0.01% |
462,500
-12,566
| -3% | -$82.4K |
|
2373
Utz Brands
UTZ
$1.07B
| $3.03M | ﹤0.01% |
200,603
+110,989
| +124% | +$1.68M |
|
2374
Agilon Health
AGL
$472M
| $3.02M | ﹤0.01% |
129,124
-5,048
| -4% | -$118K |
|
2375
America's Car Mart
CRMT
$267M
| $3.02M | ﹤0.01% |
49,442
+2,073
| +4% | +$126K |
|